Skip to main content
. 2020 Mar 17;12(3):275. doi: 10.3390/pharmaceutics12030275

Table 1.

The conventional use and route of small molecule drugs which are also under investigation for potential positive effects in wound-healing resolution and reducing fibrosis.

Drug Conventional Use Conventional Route Wound Resolution Indications
Deferoxamine (DFOA) Treating iron/aluminum toxicity SQ, IM, IV Decreases oxidative stress and necrosis [16]
Enhances neovascularization [17]
Reduces interstitial renal fibrosis [18]
Metyrapone (MTP) Inhibition of adrenal steroidgenesis PO Enhances epithelialization [19,20]
Rifampicin (RIF) Antibiotic activity PO, IV Ulcer resolution [21]
Immunomodulatory [22,23]
Pyrvinium pamoate (PYR) Anthelmintic activity PO Wnt inhibition [24]
Inhibits fibroblast survival [25]